Spectral Diagnostics (OTCMKTS:EDTXF) Trading 0.7% Higher - Should You Buy?

Spectral Diagnostics Inc. (OTCMKTS:EDTXF - Get Free Report)'s share price traded up 0.7% during mid-day trading on Friday . The company traded as high as $0.62 and last traded at $0.62. 8,059 shares were traded during trading, an increase of 18% from the average session volume of 6,819 shares. The stock had previously closed at $0.62.

Spectral Diagnostics Price Performance

The firm has a market cap of $178.11 million, a PE ratio of -8.91 and a beta of 0.22. The stock's fifty day moving average price is $0.61 and its 200-day moving average price is $0.51.

Spectral Diagnostics (OTCMKTS:EDTXF - Get Free Report) last released its earnings results on Friday, May 9th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $0.40 million for the quarter.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.